Novartis AG Logo

Novartis AG

A global medicines company that researches, develops, and markets healthcare products.

NOVN | SW

Overview

Corporate Details

ISIN(s):
CH0012005267 (+10 more)
LEI:
5493007HIVTX6SY6XD66
Country:
Switzerland
Address:
LICHTSTR. 35, 4056 BASEL

Description

Novartis AG is a global medicines company focused on the research, development, manufacturing, and marketing of innovative healthcare products. The company's mission is to reimagine medicine to improve and extend people's lives. By leveraging advanced science and technology, Novartis develops a portfolio of treatments across various therapeutic areas to address the evolving needs of patients and societies. The firm is committed to delivering high-value medicines that tackle some of the most challenging healthcare issues worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-24 23:50
FORM 6-K
English ZIP 29.5 KB
2025-11-20 12:05
FORM 6-K
English ZIP 72.8 KB
2025-11-05 22:33
FORM 6-K
English ZIP 341.4 KB
2025-11-04 22:43
424B5
English ZIP 293.8 KB
2025-11-04 02:59
FWP
English ZIP 27.5 KB
2025-11-03 14:08
424B5
English ZIP 242.2 KB
2025-10-28 22:26
DFAN14A
English ZIP 17.6 KB
2025-10-28 17:12
OWNERSHIP DOCUMENT
English ZIP 6.8 KB
2025-10-28 12:00
DFAN14A
English ZIP 27.1 KB
2025-10-28 11:07
6-K
English ZIP 412.6 KB
2025-10-27 22:14
DFAN14A
English ZIP 282.9 KB
2025-10-27 11:31
DFAN14A
English ZIP 1.4 MB
2025-10-27 11:12
DFAN14A
English ZIP 6.8 MB
2025-10-27 11:06
FORM 6-K
English ZIP 74.4 KB
2025-09-30 23:12
FORM 6-K
English ZIP 73.2 KB

Automate Your Workflow. Get a real-time feed of all Novartis AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Novartis AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Novartis AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-30 N/A Executive member Sell None 1,973,993.83 CHF
2025-03-07 N/A Non-Executive member Buy None 160,000.00 CHF
2025-02-11 N/A Executive member Sell None 312,203.18 CHF
2025-02-07 N/A Executive member Sell None 2,500,278.74 CHF
2025-02-05 N/A Executive member Sell None 1,365,687.19 CHF
2025-02-04 N/A Executive member Sell None 1,840,201.00 CHF
2025-01-30 N/A Executive member Buy None 699,424.74 CHF
2025-01-30 N/A Executive member Buy None 698,883.18 CHF
2024-12-19 N/A Executive member Sell None 1.00 CHF
2024-11-29 N/A Executive member Sell None 167,294.98 CHF

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.